MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS. [electronic resource]
Producer: 20070510Description: 1390-401 p. digitalISSN:- 1526-632X
- Adolescent
- Adult
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Brain -- pathology
- Contrast Media
- Double-Blind Method
- Female
- Follow-Up Studies
- Gadolinium
- Humans
- Image Processing, Computer-Assisted
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Multiple Sclerosis, Relapsing-Remitting -- drug therapy
- Natalizumab
- Organ Size
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.